Signaling in muscle contraction

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 2, 2015, Pages

  Kuo, Ivana Y ^a   Ehrlich, Barbara E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CALCIUM SIGNALING; CARDIOMEGALY; HEART FAILURE; HEART MUSCLE; MALIGNANT HYPERTHERMIA; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE;

CALCIUM SIGNALING; CARDIOMEGALY; HEART FAILURE; MALIGNANT HYPERTHERMIA; MODELS, BIOLOGICAL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 84922559388     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a006023     Document Type: Article

References (60)

1. Andersson DC, Marks AR. 2010. Fixing ryanodine receptor Ca leak—A novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug Discov Today 7: e151–e157.
2. Balakumar P, Jagadeesh G. 2010. Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared? Pharmacol Res 62: 365–383.
3. Baryshnikov SG, Pulina MV, Zulian A, Linde CI, Golovina VA. 2009. Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes. Am J Physiol Cell Physiol 297: C1103–C1112.
4. Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, Golovina VA. 2008. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 295: C779–C790.
5. Bezprozvanny I, Watras J, Ehrlich BE. 1991. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351: 751–754.
6. Bootman MD. 2012. Calcium signaling. Cold Spring Harb Perpsect Biol 4: a011171.
7. Bozzo C, Spolaore B,Toniolo L, Stevens L, Bastide B, Cieniewski-Bernard C, Fontana A, Mounier Y, Reggiani C. 2005. Nerveinfluence on myosin light chain phosphorylation in slow and fast skeletal muscles. FEBS J 272: 5771–5785.
8. Campbell KP, MacLennan DH, Jorgensen AO, Mintzer MC. 1983. Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glyco-protein. J Biol Chem 258: 1197–1204.
9. Cheng H, Lederer WJ, Cannell MB. 1993. Calcium sparks: Elementary events underlying excitation-contraction coupling in heart muscle. Science 262: 740–744.
10. Chien KR. 1999. Stress pathways and heart failure. Cell 98: 555–558.
11. Cole WC, Welsh DG. 2011. Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure. Arch Biochem Biophys 510: 160–173.
12. Dainese M, Quarta M, Lyfenko AD, Paolini C, Canato M, Reggiani C, Dirksen RT, Protasi F. 2009. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. FASEB J 23: 1710–1720.
13. D’Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW 2nd. 1997. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci 94: 8121–8126.
14. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. 1999. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274: 37385–37390.
15. Finch EA, Turner TJ, Goldin SM. 1991. Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. Science 252: 443–446.
16. Forstermann U, Sessa WC. 2012. Nitric oxide synthases: Regulation and function. Eur Heart J 33: 829–837, 837a–837d.
17. Handschin C, Spiegelman BM. 2006. Peroxisome proliferator-activated receptor g coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27: 728–735.
18. Hardie DG. 2012. Organismal carbohydrate and lipid homeostasis. Cold Spring Harb Perspect Biol 4: a006031.
19. Harzheim D, Talasila A, Movassagh M, Foo RS, Figg N, Bootman MD, Roderick HL. 2010. Elevated InsP3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes. Channels (Austin) 4: 67–71.
20. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. 1994. Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434–442.
21. He WQ, Peng YJ, Zhang WC, Lv N, Tang J, Chen C, Zhang CH, Gao S, Chen HQ, Zhi G, et al. 2008. Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology 135: 610–620.
22. Hemmings BA, Restuccia DF. 2012. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 4: a011189.
23. Ibrahim M, Gorelik J, Yacoub MH, Terracciano CM. 2011. The structure and function of cardiac t-tubules in health and disease. Proc Biol Sci 278: 2714–2723.
24. Kiss E, Muranyi A, Csortos C, Gergely P, Ito M, Hartshorne DJ, Erdodi F. 2002. Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton. Biochem J 365: 79–87.
25. Klein MG, Cheng H, Santana LF, Jiang YH, Lederer WJ, Schneider MF. 1996. Two mechanisms of quantized calcium release in skeletal muscle. Nature 379: 455–458.
26. Kuo IY, Wolfle SE, Hill CE. 2011. T-type calcium channels and vascular function: The new kid on the block? J Physiol 589: 783–795.
27. Lanner JT, Georgiou DK, Joshi AD, Hamilton SL. 2010. Ryanodine receptors: Structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol 2: a003996.
28. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al. 2002. Transcriptional co-activator PGC-1a drives the formation of slow-twitch muscle fibres. Nature 418: 797–801.
29. Lincoln TM. 2007. Myosin phosphatase regulatory pathways: Different functions or redundant functions? Circ Res 100: 10–12.
30. Lipskaia L, Lompre AM. 2004. Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell 96: 55–68.
31. Liu Y, Shen T, Randall WR, Schneider MF. 2005. Signaling pathways in activity-dependent fiber type plasticity in adult skeletal muscle. J Muscle Res Cell Motil 26: 13–21.
32. MacDonald JA, Eto M, Borman MA, Brautigan DL, Haystead TA. 2001. Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett 493: 91–94.
33. Matchkov VV, Kudryavtseva O, Aalkjaer C. 2012. Intracellular Ca2+ signalling and phenotype of vascular smooth muscle cells. Basic Clin Pharmacol Toxicol 110: 42–48.
34. Matsui T, Nagoshi T, Rosenzweig A. 2003. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2: 220–223.
35. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G, et al. 1995. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778–784.
36. Mishra S, Ling H, Grimm M, Zhang T, Bers DM, Brown JH. 2010. Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol 56: 598–603.
37. Miyata S, Minobe W, Bristow MR, Leinwand LA. 2000. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86: 386–390.
38. Moriki N, Ito M, Seko T, Kureishi Y, Okamoto R, Nakakuki T, Kongo M, Isaka N, Kaibuchi K, Nakano T. 2004. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27: 263–270.
39. Morrison D. 2012. MAP Kinase pathways. Cold Spring Harb Perspect Biol 4: a0011254.
40. Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J. 2010. β2-Adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327: 1653–1657.
41. Nishikimi T, Kuwahara K, Nakao K. 2011. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 57: 131–140.
42. Olesen J, Kiilerich K, Pilegaard H. 2010. PGC-1α-mediated adaptations in skeletal muscle. Pflugers Archiv Eur J Phys 460: 153–162.
43. Oliveira RS, Ferreira JC, Gomes ER, Paixao NA, Rolim NP, Medeiros A, Guatimosim S, Brum PC. 2009. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 587: 3899–3910.
44. Patel CA, Rattan S. 2006. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle. Am J Physiol Gastrointest Liver Physiol 291: G830–G837.
45. Postma AV, Denjoy I, Hoorntje TM, Lupoglazoff JM, Da Costa A, Sebillon P, Mannens MM, Wilde AA, Guicheney P. 2002. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 91: e21–e26.
46. Pritchard TJ, Kranias EG. 2009. Junctin and the histidine-rich Ca2+ binding protein: Potential roles in heart failure and arrhythmogenesis. J Physiol 587: 3125–3133.
47. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. 2006. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 27: 977–989.
48. Ronnebaum SM, Patterson C. 2010. The FoxO family in cardiac function and dysfunction. Ann Rev Physiol 72: 81–94.
49. Sanbe A, Fewell JG, Gulick J, Osinska H, Lorenz J, Hall DG, Murray LA, Kimball TR, Witt SA, Robbins J. 1999. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem 274: 21085–21094.
50. Schiaffino S, Reggiani C. 2011. Fiber types in mammalian skeletal muscles. Physiol Rev 91: 1447–1531.
51. Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y, Szigeti-Buck K, Ehrlich BE. 2006. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 116: 1668–1674.
52. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T. 2003. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411–418.
53. Steinberg SF. 2008. Structural basis of protein kinase C isoform function. Physiol Rev 88: 1341–1378.
54. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, et al. 1997. Calcium sensitization of smooth muscle mediated by a ρ-associated protein kinase in hypertension. Nature 389: 990–994.
55. Ventura-Clapier R, Mettauer B, Bigard X. 2007. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 73: 10–18.
56. Watson PA, Reusch JE, McCune SA, Leinwand LA, Luckey SW, Konhilas JP, Brown DA, Chicco AJ, Sparagna GC, Long CS, et al. 2007. Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol 293: H246–H259.
57. Wei L, Hanna AD, Beard NA, Dulhunty AF. 2009. Unique isoform-specific properties of calsequestrin in the heart and skeletal muscle. Cell Calcium 45: 474–484.
58. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. 2009. Increased muscle PGC-1a expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci 106: 20405–20410.
59. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J, Chien KR, Offermanns S. 2001. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gaq/Ga11 in cardiomyocytes. Nat Med 7: 1236–1240.
60. Zhang WC, Peng YJ, Zhang GS, He WQ, Qiao YN, Dong YY, Gao YQ, Chen C, Zhang CH, Li W, et al. 2010. Myosin light chain kinase is necessary for tonic airway smooth muscle contraction. J Biol Chem 285: 5522–5531.